Efter miljonaffären – Lipigon anställer

Pressmeddelanden   •   Jan 20, 2020 09:00 CET

Life science-bolaget Lipigon Pharmaceuticals tecknade i oktober ett mångmiljonavtal kring sitt genterapi-projekt med det börsnoterade bolaget CombiGene. Nu anställs flera nyckelkomptenser i Umeåbolaget – för att uppnå milstolparna i projektet. – Avtalet gör att vi kan växa. Det känns väldigt kul för oss – och för Umeå, säger Stefan K Nilsson, vd på Lipigon.

Lipigon recruits new talent after multi-million SEK deal

Pressmeddelanden   •   Jan 20, 2020 09:00 CET

Life science company Lipigon Pharmaceuticals has recruited two new members of staff following the signing of a multi-million SEK agreement for its gene therapy project with listed Nordic company CombiGene. The new appointments will bring additional knowledge and skills to the Umeå-based company that will help it reach project milestones in the years ahead.

Umeå Biotech Incubator öppnar ny kontorsyta i Umeå

Pressmeddelanden   •   Dec 11, 2019 08:30 CET

Nu skapar Umeå Biotech Incubator nya företagsplatser på Tvistevägen vid Umeå universitetet. – Det blir en ny och fräsch co-workingyta för Umeås startups – där företagen kan tillväxa och samverka, säger Jennie Ekbeck, vd på Umeå Biotech Incubator.

Umeå Biotech Incubator opens new office space in Umeå

Pressmeddelanden   •   Dec 11, 2019 08:30 CET

Now Umeå Biotech Incubator is creating new business areas on Tvistevägen near Umeå University. ”It will be a new and modern co-working space for Umeå's startups – where the companies can grow and collaborate,” says Jennie Ekbeck, CEO of Umeå Biotech Incubator.

Beviljas miljoner – ska bekämpa antibiotikaresistens

Pressmeddelanden   •   Dec 04, 2019 08:26 CET

Umeåföretaget Quretech Bio är en viktig spelare i kampen mot antibiotikaresistens. Nu har forskarna bakom bolaget fått 5 miljoner kronor från Familjen Erling-Perssons stiftelse för att göra resistenta bakterier känsliga för antibiotika igen. – Pengarna är avgörande för att vi ska kunna göra kritiska experiment, säger Jörgen Johansson, medgrundare av Quretech Bio.

Awarded millions in fight against antibiotic resistance

Pressmeddelanden   •   Dec 04, 2019 08:26 CET

Researchers from the Umea pharmaceutical research company Quretech Bio have been granted SEK 5 million by the Erling-Persson Family Foundation to make resistant bacteria sensitive to antibiotics again. “We are delighted and extremely grateful. This money is vital in allowing us to continue conducting critical experiments” says Jörgen Johansson, Co-founder of Quretech Bio.

Expertrådgivare kliver in i Lipum

Pressmeddelanden   •   Dec 02, 2019 10:36 CET

Nu tillför Umeåbolaget Lipum mer expertkunskap till företaget. Professor Anders Fasth kliver in som rådgivare i arbetet med att ta fram nya läkemedel mot inflammatoriska sjukdomar. – Det är väldigt glädjande att han kommer in i vårt team, säger Einar Pontén, vd på Lipum.

Expert advisor enters Lipum

Pressmeddelanden   •   Dec 02, 2019 10:29 CET

​Now Umeå company Lipum brings more expertise to the company. Professor Anders Fasth steps in as an advisor in the development of medicines for inflammatory diseases. “It is very gratifying that he joins the team,” says Einar Pontén, CEO of Lipum.

Lipigon signs multi-million gene therapy deal

Pressmeddelanden   •   Nov 28, 2019 12:59 CET

Life science company Lipigon Pharmaceuticals has signed an agreement for its gene therapy project with listed company CombiGene. “If everything goes well this agreement could potentially be worth millions. But it also enables us to develop our business in the short term, not least because we can now employ highly competent staff in Umeå,” says Stefan K Nilsson, CEO of Lipigon.

Spinchem shares 40 million SEK in research project

Pressmeddelanden   •   Nov 26, 2019 10:42 CET

The Umeå company Spinchem shares about 40 million SEK in an international research project funded by the European Union. ”This is good timing for SpinChem since our strategy is to create new environmentally friendly, bio-based processes for industry,” says Emil Byström, CEO of Spinchem.

Kontaktpersoner 2 kontaktpersoner

  • Presskontakt
  • Head of PR and Communications
  • PR and Communications
  • elxminnz.oeblszqsokbn@zzubfdi.eqsekq
  • +46706125561

Om Umeå Biotech Incubator

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Adress

  • Umeå Biotech Incubator
  • Tvistevägen 48C
  • 907 36 Umeå
  • Sverige

Länkar